Table 3.
Multivariable analysis of the probability of undergoing any neurogenic bowel procedure, NSBPR (2009–2014)
| Variables | Adjusted odds ratio (95% CI) | P-value |
|---|---|---|
| Age group at annual visit | < 0.001 | |
| Younger than 2 | Reference | |
| 2 to < 5 | 2.45 (1.04–5.78) | |
| 5 to < 10 | 12.73 (5.84–27.76) | |
| 10 to < 13 | 27.87 (12.72–61.11) | |
| 13 to < 18 | 31.13 (14.37–67.43) | |
| 18 to < 22 | 34.06 (15.60–74.36) | |
| 22+ | 16.46 (7.51–36.09) | |
| Sex | 0.015 | |
| Male | Reference | |
| Female | 1.20 (1.04–1.39) | |
| Race/ethnicity | 0.002 | |
| Non-Hispanic white | Reference | |
| Non-Hispanic black | 0.79 (0.58–1.07) | |
| Hispanic or Latino | 0.64 (0.50–0.81) | |
| Other | 0.79 (0.57–1.08) | |
| Spina bifida type | 0.012 | |
| Myelomeningocele | Reference | |
| Non-myelomeningocele | 0.74 (0.58–0.94) | |
| Function level of lesion | < 0.001 | |
| Thoracic | Reference | |
| Lumbar | 0.82 (0.65–1.03) | |
| Sacral | 0.54 (0.40–0.74) | |
| Mobility status | 0.011 | |
| Community ambulators | Reference | |
| Household ambulators | 1.40 (1.04–1.88) | |
| Therapeutic ambulators | 1.35 (1.00–1.81) | |
| Non-ambulators | 1.43 (1.14–1.80) | |
| Insurance | 0.002 | |
| Any private | Reference | |
| Non-private | 0.78 (0.67–0.91) | |
| Clinic | < 0.001 | |
| 1 | Reference | |
| 2 | 0.54 (0.26–1.14) | |
| 3 | 0.46 (0.21–1.01) | |
| 4 | 2.02 (1.36–3.02) | |
| 5 | 1.65 (1.14–2.40) | |
| 6 | 1.57 (1.07–2.30) | |
| 7 | 2.61 (1.82–3.74) | |
| 8 | 4.23 (2.97–6.04) | |
| 9 | 1.44 (0.93–2.23) | |
| 10 | 0.54 (0.33–0.90) | |
| 11 | 0.57 (0.37–0.89) | |
| 12 | 1.31 (0.91–1.88) | |
| 13 | 1.63 (1.16–2.29) | |
| 14 | 1.17 (0.80–1.70) | |
| 15 | 0.86 (0.53–1.41) | |
| 16 | 2.38 (1.68–3.36) | |
| 17 | 2.51 (1.38–4.58) | |
| 18 | 1.53 (1.04–2.26) | |
| 19 | 0.20 (0.05–0.84) |